ArticleInterdisciplinary cardiovascular and thoracic surgery2026
Median Sternotomy Coronary Artery Bypass Surgery for Isolated Left Anterior Descending Disease: Outcomes from The Netherlands Heart Registration.
Article in Interdisciplinary cardiovascular and thoracic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Benchmarking Sternotomy in Isolated Left Anterior Descending Disease: The Need to Account for the Full Selection Pathway.Interdisciplinary cardiovascular and thoracic surgery · 2026Article
- Reply to Fatih Kizilyel and Bedirhan Bugra Bayici.Interdisciplinary cardiovascular and thoracic surgery · 2026Article
Corrections and comments
- Commented on by
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThis study evaluates the nationwide outcome of single-vessel left anterior descending artery (LAD) revascularization through median sternotomy in the Netherlands and to analyse the impact of the surgical technique (off-pump versus on-pump).
methodsA retrospective multicentre cohort study was conducted, including 2592 patients who underwent isolated coronary artery bypass surgery for single-vessel LAD disease from 2013 to 2022. Data were obtained from the Netherlands Heart Registration (NHR) database. The study analysed postoperative 30 days and 1 year mortality, postoperative complications, and 5-year postoperative outcome. Propensity score matching (PSM) was used to adjust for baseline differences between the off-pump (OPCAB) and on-pump (ONCAB) groups.
resultsIn the total cohort, 30-day mortality was 0.9%, with a 1-year mortality of 1.9%. The distribution of surgical technique was stable during the study period (60% OPCAB and 40% ONCAB). After PSM, there was less need for perioperative blood transfusions with OPCAB (7.0% versus 16.5%, P < .001). There was no significant difference in 30-day mortality (0.7% versus 0.6%, P = .762) and 1-year mortality (1.5% versus 1.6%, P = .932) between OPCAB and ONCAB. The Kaplan-Meier analysis demonstrated significant difference in target vessel reintervention (TVR) in favour for ONCAB (P = .028) but no difference in survival.
conclusionsSingle-vessel LAD revascularization through median sternotomy in the Netherlands shows good procedural outcomes, comparable for both OPCAB and ONCAB. These data might serve as a benchmark for future studies on minimally invasive revascularization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.